# Bioequivalence of Orfadin Suspension Compared to Orfadin Capsules, and the Effect of Food on the Bioavailability of the Suspension

> **NCT01682538** · PHASE1 · COMPLETED · sponsor: **Swedish Orphan Biovitrum** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Nitisinone, capsule
- **DRUG:** Nitisinone, suspension

## Key facts

- **NCT ID:** NCT01682538
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01682538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01682538, "Bioequivalence of Orfadin Suspension Compared to Orfadin Capsules, and the Effect of Food on the Bioavailability of the Suspension". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01682538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*